This engineered protein, HAC-PD1, not only prolonged the survival rates of tumor-bearing mice more successfully than conventional anti PD-L1 monoclonal antibodies, but it also showed favorable properties when used as a 64Cu-labeled PET tracer [66]. Here, CD274 is linked to neoplasm.